In summary, cancer cells rewire the BCAA metabolic network at multiple points—from transporter upregulation (importing more leucine) to enzyme modulation (tuning BCAT and BCKDH activity)—in order to optimize BCAA utilization for malignant growth (Fig. 1). Here, PPM1K is linked to cancer.